Dr. Mary Zhang, MD, PhD
Claim this profileUniversity of Ottawa Heart Institute
Studies Coronary Artery Disease
Studies Mitral Valve Regurgitation
2 reported clinical trials
4 drugs studied
Affiliated Hospitals
Clinical Trials Mary Zhang, MD, PhD is currently running
Percutaneous vs Surgical Mitral Valve Repair
for Mitral Valve Regurgitation
Ischemic mitral regurgitation (MR) and coronary artery disease is common and associated with significant morbidity and mortality. Ischemic MR has been traditionally treated surgically through either valve repair or replacement at the time of concomitant bypass grafting. Although patients with ischemic MR represent a heterogeneous group, outcomes for these patients over the intermediate term is poor owing to left ventricle (LV) dysfunction causing MR and the presence of coronary disease, which portends poor survival. There is an emergence of percutaneous therapies to treat MR which have been shown to be a less invasive, safe, and viable approach to treat comorbid patients. The decision to treat ischemic MR either surgically or percutaneously is influenced by the presence of coronary disease and the ability to provide adequate revascularization. Mitral valve surgery concomitant to surgical revascularization, however, is associated with a several fold increase in mortality. In fact, the incremental risk increase is further magnified in high-risk patients. We therefore propose a novel prospective study to guide intervention for ischemic MR. Patients will be randomized to undergo surgical therapy with either mitral repair/replacement and/or concomitant coronary artery bypass grafting OR percutaneous mitral repair, followed by coronary artery bypass grafting.
Recruiting1 award N/A2 criteria
Minimally Invasive vs. Conventional Heart Bypass
for Coronary Artery Disease
This trial compares a less invasive heart surgery to traditional open-chest surgery in patients with multiple blocked heart arteries. The goal is to see if the less invasive method helps patients recover quicker and improve their quality of life. The less invasive surgery was developed to allow adequate exposure and complete treatment from a small incision without the need for a heart-lung machine.
Recruiting1 award N/A4 criteria
More about Mary Zhang, MD, PhD
Clinical Trial Related3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Mary Zhang, MD, PhD has experience with
- Percutaneous Mitral Valve Repair
- Surgical Mitral Valve Repair/replacement
- Conventional CABG
- MICS CABG
Breakdown of trials Mary Zhang, MD, PhD has run
Coronary Artery Disease
Mitral Valve Regurgitation
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mary Zhang, MD, PhD specialize in?
Mary Zhang, MD, PhD focuses on Coronary Artery Disease and Mitral Valve Regurgitation. In particular, much of their work with Coronary Artery Disease has involved treating patients, or patients who are undergoing treatment.
Is Mary Zhang, MD, PhD currently recruiting for clinical trials?
Yes, Mary Zhang, MD, PhD is currently recruiting for 2 clinical trials in Ottawa Ontario. If you're interested in participating, you should apply.
Are there any treatments that Mary Zhang, MD, PhD has studied deeply?
Yes, Mary Zhang, MD, PhD has studied treatments such as Percutaneous mitral valve repair, Surgical mitral valve repair/replacement, Conventional CABG.
What is the best way to schedule an appointment with Mary Zhang, MD, PhD?
Apply for one of the trials that Mary Zhang, MD, PhD is conducting.
What is the office address of Mary Zhang, MD, PhD?
The office of Mary Zhang, MD, PhD is located at: University of Ottawa Heart Institute, Ottawa, Ontario K1Y 4W7 Canada. This is the address for their practice at the University of Ottawa Heart Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.